Characterization of absorbable collagen sponges as recombinant human bone morphogenetic protein-2 carriers

被引:42
|
作者
Friess, W
Uludag, H
Foskett, S
Biron, R
Sargeant, C
机构
[1] Univ Erlangen Nurnberg, Dept Pharmaceut Technol, D-91058 Erlangen, Germany
[2] Univ Alberta, Dept Biomed Engn, Edmonton, AB T6G 2G3, Canada
[3] Genet Inst Inc, Andover, MA 01810 USA
关键词
collagen; bone morphogenetic protein; sterilization; crosslinking;
D O I
10.1016/S0378-5173(99)00128-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
For clinical use recombinant human bone morphogenetic protein-2 (rhBMP-2) is soaked onto an absorbable collagen sponge (ACS) for bone regeneration. Therefore, loss of rhBMP-2 upon mechanical handling during implantation and a potential effect of the carrier on in vivo retention is of interest. The interactions between drug and carrier were looked at from the application mode and the amount of protein which can be mechanically expressed from the combination was investigated. The results indicated that rhBMP-2 binds to the collagen system. The most hydrophilic double extended homodimer showed the least binding affinity to ACS. By extending the waiting time between soaking and implantation, protein incorporation could be increased. In addition, the amount of rhBMP-2 which could be expressed was reduced by heavier ACS material and allowed for a shorter waiting period, especially at lower rhBMP-2 concentration. Crosslinking of ACS with formaldehyde led to reduced binding of rhBMP-2 to collagen either by direct hindrance of binding or reduction in swelling and number of binding sites available. Higher product pH or anion concentration enabled to increase rhBMP-2 incorporation but was limited by the potential precipitation of rhBMP-2. Despite a variety of chemical changes of ACS by ethylene oxide sterilization incorporation was not changed significantly. The in vivo release kinetics of I-125-rhBMP-2 from the collagen sponge were studied using a rat ectopic implant model. The ACS/rhBMP-2 systems tested demonstrated small but significant differences in the in vivo retention of rhBMP-2. Consequently, it is important to have as little variability in pH, anion concentration, crosslinking, and ACS mass as possible to achieve consistent or maximum binding and to avoid rhBMP-2 precipitation. Furthermore, these characteristics can be important for other in vivo applications. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:51 / 60
页数:10
相关论文
共 50 条
  • [31] Construction and characterization of an adenoviral vector encoding human bone morphogenetic protein-2
    Peng, Liangquan
    Chen, Kang
    Zhu, Weimin
    Lu, Wei
    Xu, Pan
    Huang, Yong
    Kuai, Shengzheng
    Deng, Zhenhan
    Wang, Daping
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2020, 48 (03)
  • [32] Comparison between heparin-conjugated fibrin and collagen sponge as bone morphogenetic protein-2 carriers for bone regeneration
    Hee Seok Yang
    Wan-Geun La
    Yong-Min Cho
    Wangsoo Shin
    Guw-Dong Yeo
    Byung-Soo Kim
    Experimental & Molecular Medicine, 2012, 44 : 350 - 355
  • [33] A porcine collagen-derived matrix as a carrier for recombinant human bone morphogenetic protein-2 enhances spinal fusion in rats
    Miyazaki, Masashi
    Morishita, Yuichiro
    He, Wubing
    Hu, Ming
    Sintuu, Chananit
    Hymanson, Henry J.
    Falakassa, Jonathan
    Tsumura, Hiroshi
    Wang, Jeffrey C.
    SPINE JOURNAL, 2009, 9 (01) : 22 - 30
  • [34] Comparison of Bone Regeneration in Different Forms of Bovine Bone Scaffolds with Recombinant Human Bone Morphogenetic Protein-2
    Seok, Hyun
    Kim, Hee-Youl
    Kang, Dong-Cheol
    Park, Jung-Ho
    Park, Jong Hoon
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (20)
  • [35] Recombinant human bone morphogenetic: Protein-2 stimulation of bone formation around endosseous dental implants
    Cochran, DL
    Schenk, R
    Buser, D
    Wozney, JM
    Jones, AA
    JOURNAL OF PERIODONTOLOGY, 1999, 70 (02) : 139 - 150
  • [36] In situ osteogenesis: Regeneration of 10-cm mandibular defect in porcine model using recombinant human bone morphogenetic protein-2 (rhBMP-2) and helistat absorbable collagen sponge
    Carstens, MH
    Chin, M
    Li, XJ
    JOURNAL OF CRANIOFACIAL SURGERY, 2005, 16 (06) : 1033 - 1042
  • [37] In vitro cellular responses to bioerodible particles loaded with recombinant human bone morphogenetic protein-2
    Puleo, DA
    Huh, WW
    Duggirala, SS
    DeLuca, PP
    JOURNAL OF BIOMEDICAL MATERIALS RESEARCH, 1998, 41 (01): : 104 - 110
  • [38] Recombinant human bone morphogenetic protein-2/atelocollagen composite as a new material for ossicular reconstruction
    Takeuchi, Ayako
    Tsujigiwa, Hidetsugu
    Murakami, Jun
    Kawasaki, Akihiro
    Takeda, Yasushi
    Fukushima, Kunihiro
    Rodriguez, Andrea P.
    Nagatsuka, Hitoshi
    Yamada, Masao
    Nishizaki, Kazunori
    JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2009, 89A (01) : 36 - 45
  • [39] Bone regeneration using collagen type I vitrigel with bone morphogenetic protein-2
    Zhao, Jiyuan
    Shinkai, Masashige
    Takezawa, Toshiaki
    Ohba, Shinsuke
    Chung, Ung-il
    Nagamune, Teruyuki
    JOURNAL OF BIOSCIENCE AND BIOENGINEERING, 2009, 107 (03) : 318 - 323
  • [40] Safety of transforaminal lumbar interbody fusion and intervertebral recombinant human bone morphogenetic protein-2
    Villavicencio, AT
    Burneikiene, S
    Nelson, EL
    Bulsara, KR
    Favors, M
    Thramann, J
    JOURNAL OF NEUROSURGERY-SPINE, 2005, 3 (06) : 436 - 443